Chester County News and Community Website
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has announced new funding to support quality improvement projects aimed at advancing breast cancer outcomes. The …
NCCN Oncology Research Program Announces New Funding for Breast Cancer Quality Initiatives Read More
AUDUBON, PA — CertaPro Painters® has launched its seventh annual Paint it Pink campaign in partnership with the Breast Cancer Research Foundation (BCRF) and Breast Cancer Canada, continuing its mission …
CertaPro Painters Launches Seventh Annual ‘Paint It Pink’ Campaign for Breast Cancer Research Read More
PHILADELPHIA, PA & SAN FRANCISCO, CA — Dispatch Bio emerged from stealth this past week with a mission as ambitious as it is urgent: to develop a universal treatment for …
Dispatch Bio Launches With $216M and Bold Mission to Tackle All Solid Tumors Read More
WILMINGTON, DE — A groundbreaking study by ChristianaCare’s Cawley Center for Translational Cancer Research has identified key factors behind Delaware’s elevated rates of advanced breast cancer and laid the groundwork for …
New ChristianaCare Study Pinpoints Causes Behind Delaware’s Breast Cancer Hotspots Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has awarded two new research grants to support studies on zipalertinib, a promising therapy for Non-Small …
NCCN Awards Grants to Advance Innovative Lung Cancer Research on Zipalertinib Read More PLYMOUTH MEETING, PA — A new study published in the June 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network highlights the life-changing impact of a telehealth-based care program …
Telehealth Program Improves Quality of Life for Older Cancer Patients, Study Finds Read More
KING OF PRUSSIA, PA — SEED Therapeutics Inc. presented compelling developments from its cancer research programs at the 2025 Annual Meeting of the American Association for Cancer Research (AACR) in …
SEED Therapeutics Unveils Groundbreaking Advances in Cancer Research at AACR 2025 Read More
KING OF PRUSSIA, PA — SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., has announced a major advancement in oncology with the discovery of PVTX-405, a potent …
SK Life Science Labs Unveils Breakthrough in Cancer Therapy with PVTX-405 Read More
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) presented preclinical and translational data on its clinical asset, CT-95, at the 2025 American Association for Cancer Research (AACR) Annual Meeting. The …
Context Therapeutics Showcases Promising CT-95 Data at AACR Annual Meeting Read More KING OF PRUSSIA, PA — SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., has presented groundbreaking research at the American Association for Cancer Research (AACR) Annual Meeting …
SK Life Science Labs Unveils Promising Cancer Research at AACR Annual Meeting Read More